Trial intelligence / Profile preview

Paliperidone ER therapeutic window PET study

2008-003340-11Phase 4Terminated

Sponsor
Janssen-Cilag
Start
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of paliperidone and risperidone in schizophrenia (3 arms), sponsored by Janssen-Cilag. Started Aug 2008; status: terminated.

02

Drugs

paliperidonerisperidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on 2008-003340-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003340-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call